About Us
About Guard Therapeutics
Vision, mission & goal
The Board
Management
Research & Development
Acute kidney injury
RMC-035 (ROSgard)
Clinical development
Patents
Investor Relations
Financial calender
Financial reports
Share information
Corporate governance
General meetings
News & Media
Press releases
Event calender
Analyses and presentations
In media
Subscribe
Contact
Swe
Search
Presentation
19 Sep 2023
/
Investor webcast: CEO Tobias Agervald and CMO Michael Reusch presents AKITA Top-line results
Link to presentation:
https://financialhearings.com/event/47345